CD1D and myeloid sarcoma: Similar to CD1d‐positive cell density in brain tissue, there were increases in the percentage of cells staining positive for CD1d in MS tissue relative to control tissues (9.860 ± 8.655% vs. 1.078 ± 0.8249%, respectively, P = 0.0007) (Figure 3C).